Primary Site >> Liver Cancer
Gene >> TCF4
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway. PMID: 12447697 Ref: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. PMID: 12481159 |
Ref: Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. PMID: 15040893 |
Ref: Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo. PMID: 18593980 |
Ref: Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. PMID: 19662654 |
Ref: The transforming growth factor-alpha and cyclin D1 genes are direct targets of beta-catenin signaling in hepatocyte proliferation. PMID: 21145869 |
Ref: A double-negative feedback loop between Wnt-beta-catenin signaling and HNF4alpha regulates epithelial-mesenchymal transition in hepatocellular carcinoma. PMID: 24101726 |
Ref: Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition. PMID: 24434019 Ref: SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/beta-catenin/TCF4 cascade. PMID: 25001176 Ref: Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying beta-catenin degradation. PMID: 25056121 Ref: Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis. PMID: 25160513 Ref: TRIB2 inhibits Wnt/beta-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, beta-TrCP, COP1 and Smurf1, in liver cancer cells. PMID: 25311538 |
Ref: Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells. PMID: 25469885 Ref: Farnesoid X receptor associates with beta-catenin and inhibits its activity in hepatocellular carcinoma. PMID: 25650661 Ref: The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular Carcinoma. PMID: 26356417 |
Ref: MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/beta-catenin signaling pathway. PMID: 27058905 Ref: Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding. PMID: 27542264 |
Ref: Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. PMID: 28526827 Ref: Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma. PMID: 28923827 |
Ref: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. PMID: 29361949 Ref: The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. PMID: 29785050 Ref: miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1. PMID: 29858084 Ref: DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/beta-catenin pathway. PMID: 29867138 Ref: CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma. PMID: 29981747 Ref: MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma. PMID: 30145863 Ref: SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying beta-catenin degradation. PMID: 30249289 Ref: NOP7 interacts with beta-catenin and activates beta-catenin/TCF signaling in hepatocellular carcinoma cells. PMID: 30319277 |